Penetration of metallic nanoparticles in human full-thickness skin.
暂无分享,去创建一个
M. López-Quintela | M. Isola | M. Ennas | Maria Grazia Ennas | M Arturo López-Quintela | B. Baroli | F. Loffredo | R. Pinna | Biancamaria Baroli | Felice Loffredo | Michela Isola | Raimondo Pinna | M. López‐Quintela
[1] P. Riley. Molecules in focusMelanin , 1997 .
[2] Richard H. Guy,et al. The Electrical Characteristics of Human Skin in Vivo , 1995, Pharmaceutical Research.
[3] H. Junginger,et al. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.
[4] Geoffrey Lee. Prediction of Percutaneous Penetration , 1997 .
[5] Sverre Grimnes,et al. Measuring depth depends on frequency in electrical skin impedance measurements , 1999 .
[6] H I Maibach,et al. Skin permeability in vivo: comparison in rat, rabbit, pig and man. , 1972, The Journal of investigative dermatology.
[7] Ronni Wolf,et al. Percutaneous absorption and delivery systems3 , 2001 .
[8] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[9] J. Lademann,et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.
[10] J. Rosell,et al. Skin impedance from 1 Hz to 1 MHz , 1988, IEEE Transactions on Biomedical Engineering.
[11] J A Bouwstra,et al. Skin structure and mode of action of vesicles. , 2002, Advanced drug delivery reviews.
[12] Richard H. Guy,et al. Current Status and Future Prospects of Transdermal Drug Delivery , 1996, Pharmaceutical Research.
[13] P. Hoet,et al. Nanoparticles – known and unknown health risks , 2004, Journal of nanobiotechnology.
[14] R O Potts,et al. Stratum corneum lipid phase transitions and water barrier properties. , 1987, Biochemistry.
[15] H I Maibach,et al. Percutaneous penetration of some pesticides and herbicides in man. , 1974, Toxicology and applied pharmacology.
[16] G. Cevc. Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.
[17] I. Gwynn,et al. Backscattered electron imaging of the undersurface of resin‐embedded cells by field‐emission scanning electron microscopy , 1995, Journal of microscopy.
[18] A. Kierszenbaum. Histology and Cell Biology , 2001 .
[19] Karluss Thomas,et al. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[20] K. Higaki,et al. Strategies for overcoming the stratum corneum , 2003 .
[21] J. James,et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[22] José Rivas,et al. Chemical Reactions in Microemulsions: A Powerful Method to Obtain Ultrafine Particles , 1993 .
[23] J. Bouwstra,et al. Structure of the skin barrier and its modulation by vesicular formulations. , 2003, Progress in lipid research.
[24] Ulrike Blume-Peytavi,et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. , 2006, The Journal of investigative dermatology.
[25] José Rivas,et al. Advances in the Preparation of Magnetic Nanoparticles by the Microemulsion Method , 1997 .
[26] P. Elias. Stratum corneum defensive functions: an integrated view. , 2005, The Journal of investigative dermatology.
[27] J. Bouwstra,et al. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. , 2004, The Journal of investigative dermatology.
[28] J. Bouwstra,et al. Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1. , 2002, The Journal of investigative dermatology.
[29] H. Hofmann,et al. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .
[30] J. Dubochet,et al. Nanostructure of the epidermal extracellular space as observed by cryo-electron microscopy of vitreous sections of human skin. , 2005, The Journal of investigative dermatology.
[31] M. C. Bonner,et al. Transfollicular drug delivery--is it a reality? , 2005, International journal of pharmaceutics.
[32] S. Mitragotri,et al. Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. , 2001, Journal of pharmaceutical sciences.
[33] Nigel J Walker,et al. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[34] R. Langer,et al. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. , 1997, Journal of pharmaceutical sciences.
[35] J. Hadgraft. Skin, the final frontier. , 2001, International journal of pharmaceutics.
[36] V Wendel,et al. Distribution of sunscreens on skin. , 2002, Advanced drug delivery reviews.
[37] Jenny R. Roberts,et al. Skin as a route of exposure and sensitization in chronic beryllium disease. , 2003, Environmental health perspectives.
[38] A. Ghanem,et al. Studies on the Effects of Applied Voltage and Duration on Human Epidermal Membrane Alteration/Recovery and the Resultant Effects upon Iontophoresis , 1994, Pharmaceutical Research.
[39] M. López-Quintela,et al. Dynamic Light Scattering in Transient Reversible Gels , 2000 .
[40] Michael P Holsapple,et al. Forum series: research strategies for safety evaluation of nanomaterials. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[41] B. W. Barry,et al. Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[42] R H Guy,et al. Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[43] Ulrich F Schaefer,et al. pH profiles in human skin: influence of two in vitro test systems for drug delivery testing. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[44] Lin He,et al. Nanoparticles for bioanalysis. , 2003, Current opinion in chemical biology.
[45] Robert Langer,et al. Transdermal drug delivery: past progress, current status, and future prospects. , 2004, Advanced drug delivery reviews.
[46] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[47] P. Wertz,et al. Elasticity of vesicles affects hairless mouse skin structure and permeability. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[48] Lasse Murtomäki,et al. Electrochemical Characterization of Human Skin by Impedance Spectroscopy: The Effect of Penetration Enhancers , 1993, Pharmaceutical Research.
[49] N. Weiner,et al. Targeted delivery to the pilosebaceous unit via liposomes , 1996 .
[50] J. Zatz,et al. SKIN PENETRATION ENHANCEMENT BY SURFACTANTS , 1997 .